| |
| |
|
| Insider
Information: |
Olson William C |
| Relationship: |
Senior VP, Research an... |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
45,544 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$186,730 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
45,544 |
|
|
| Total
Value |
$186,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Senior VP, Research an... |
2012-06-20 |
45,544 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-01-03 |
4 |
OE |
$21.88 |
$7,921 |
D/D |
362 |
24,374 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-04-02 |
4 |
D |
$24.10 |
$8,556 |
D/D |
(355) |
24,141 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-04-02 |
4 |
OE |
$20.13 |
$7,931 |
D/D |
394 |
24,496 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-06-20 |
4 |
D |
$22.83 |
$22,829 |
D/D |
(1,000) |
23,141 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-07-02 |
4 |
D |
$22.01 |
$30,968 |
D/D |
(1,407) |
32,664 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-07-02 |
4 |
OE |
$18.71 |
$28,926 |
D/D |
1,546 |
34,071 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,333 |
32,525 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-10-01 |
4 |
OE |
$19.03 |
$8,868 |
D/D |
466 |
33,180 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$9,493 |
D/D |
(424) |
32,756 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-12-03 |
4 |
AS |
$19.03 |
$76,112 |
D/D |
(4,000) |
32,756 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2007-12-03 |
4 |
OE |
$4.00 |
$16,000 |
D/D |
4,000 |
28,756 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$9,358 |
D/D |
(519) |
32,868 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-01-02 |
4 |
OE |
$15.33 |
$8,738 |
D/D |
570 |
33,387 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-04-01 |
4 |
OE |
$6.52 |
$10,276 |
D/D |
1,576 |
34,613 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$11,006 |
D/D |
(1,435) |
33,178 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-06-23 |
4 |
D |
$17.01 |
$59,546 |
D/D |
(3,500) |
29,678 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-07-01 |
4 |
OE |
$13.64 |
$31,317 |
D/D |
2,296 |
32,044 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-07-01 |
4 |
D |
$16.05 |
$33,528 |
D/D |
(2,089) |
29,955 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
36,622 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$14,083 |
D/D |
(1,011) |
37,604 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2008-10-01 |
4 |
OE |
$6.53 |
$9,691 |
D/D |
1,484 |
38,615 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$12,577 |
D/D |
(1,171) |
37,827 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-01-02 |
4 |
OE |
$9.13 |
$11,750 |
D/D |
1,287 |
38,998 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-04-01 |
4 |
D |
$6.65 |
$12,183 |
D/D |
(1,832) |
36,163 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
VP, Research & Development |
• – – |
2009-04-01 |
4 |
OE |
$5.65 |
$11,379 |
D/D |
2,014 |
38,177 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
